Sham injections

DRUG2 trials

Sponsors

Mayo Clinic, Novartis Pharmaceuticals

Conditions

Breast CancerVisual Impairment Due to Diabetic Macular Edema

Phase 3

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema

TerminatedNCT01131585

Novartis PharmaceuticalsVisual Impairment Due to Diabetic Macular Edema

Start: 2010-06-30End: 2011-07-31Updated: 2012-08-30

Unknown Phase

Chronic Post Breast Surgery Pain

TerminatedNCT00847067

Mayo ClinicBreast Cancer

Start: 2009-02-28End: 2010-04-30Updated: 2010-06-11